Welcome to kongre.net
Speaker
Vice President - New Drug Development, Nuwacell
Luyan Jiao, Vice President - New Drug Development at Nuwacell, spoke at 6th iPSC Drug Development Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Advancing Hypoimmune iPSC‑Derived Dopaminergic Progenitors (NCR201) Toward Clinical Translation in Parkinson’s Disease”.
9–10 Sept 2026Boston, United States of America
Clinical Manufacturing Head, Cartherics Pty Ltd
Chief Scientific Officer, Logomix, Inc.
Head of Research & Development, Karis Bio
President & Chief Technology Officer, Cellistic
Chief Executive Officer & Co-Founder, Theseus Therapies
Vice President, Corporate Innovation, Catalent, Inc.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Luyan Jiao, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].